Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Adma Biologics (ADMA)

Adma Biologics (ADMA)
19.04 x 10 19.47 x 5
Post-market by (Cboe BZX)
19.40 +0.72 (+3.85%) 04/11/25 [NASDAQ]
19.04 x 10 19.47 x 5
Post-market 19.41 +0.01 (+0.05%) 18:20 ET
Profile for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Adma Biologics 465 STATE ROUTE 17 RAMSEY NJ 07446 USA

www.admabiologics.com Employees: 685 P: 201-478-5552 F: 201-478-5553

Sector:

Medical

Description:

ADMA Biologics, Inc. is a specialty immune globulin company. It develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious diseases. The Company's target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. Its lead product candidate, RI-002, which is in Phase III clinical trial, is intended for the treatment of primary immune deficiency disease. ADMA Biologics, Inc. is headquartered in Ramsey, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 4,585,966
Enterprise Value, $K 4,555,156
Shares Outstanding, K 236,390
Annual Sales, $ 426,450 K
Annual Net Income, $ 197,670 K
Last Quarter Sales, $ 117,550 K
Last Quarter Net Income, $ 111,900 K
EBIT, $ 139,370 K
EBITDA, $ 148,220 K
60-Month Beta 0.53
% of Insider Shareholders 3.70%
% of Institutional Shareholders 75.68%
Float, K 227,644
% Float 96.30%
Short Volume Ratio 0.44

Growth:

1-Year Return 211.90%
3-Year Return 865.17%
5-Year Return 621.19%
5-Year Revenue Growth 1,352.98%
5-Year Earnings Growth 153.26%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.14 on 03/03/25
Next Earnings Date 05/08/25 [--]
Earnings Per Share ttm 0.50
EPS Growth vs. Prev Qtr -6.67%
EPS Growth vs. Prev Year 250.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ADMA Ratios

Ratio
Price/Earnings ttm 37.36
Price/Earnings forward 26.31
Price/Earnings to Growth N/A
Return-on-Equity % 51.67%
Return-on-Assets % 29.68%
Profit Margin % 46.35%
Debt/Equity 0.21
Price/Sales 10.35
Price/Cash Flow 34.48
Price/Book 12.65
Book Value/Share 1.48
Interest Coverage 10.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar